J Korean Med Sci.  2016 May;31(5):709-714. 10.3346/jkms.2016.31.5.709.

Influenza Vaccination Coverage Rate according to the Pulmonary Function of Korean Adults Aged 40 Years and Over: Analysis of the Fifth Korean National Health and Nutrition Examination Survey

• Cha SH
• Paik JH
• Lee MR
• Yang H
• Park SG
• Jeon YJ
• Yoo S

• KMID: 2373667
• DOI: http://doi.org/10.3346/jkms.2016.31.5.709

Abstract

Influenza vaccination is an effective strategy to reduce morbidity and mortality, particularly for those who have decreased lung functions. This study was to identify the factors that affect vaccination coverage according to the results of pulmonary function tests depending on the age. In this cross-sectional study, data were obtained from 3,224 adults over the age of 40 who participated in the fifth National Health and Nutrition Examination Survey and underwent pulmonary function testing in 2012. To identify the factors that affect vaccination rate, logistic regression analysis was conducted after dividing the subjects into two groups based on the age of 65. Influenza vaccination coverage of the entire subjects was 45.2%, and 76.8% for those aged 65 and over. The group with abnormal pulmonary function had a higher vaccination rate than the normal group, but any pulmonary dysfunction or history of COPD did not affect the vaccination coverage in the multivariate analysis. The subjects who were 40-64 years-old had higher vaccination coverage when they were less educated or with restricted activity level, received health screenings, and had chronic diseases. Those aged 65 and over had significantly higher vaccination coverage only when they received regular health screenings. Any pulmonary dysfunction or having COPD showed no significant correlation with the vaccination coverage in the Korean adult population.

Keyword

Influenza; Vaccination; Respiratory Function Test; Respiratory Disease, Chronic Obstructive

MeSH Terms

Adult
Aged
Asian Continental Ancestry Group
Cross-Sectional Studies
Female
Humans
Influenza Vaccines/*immunology
Influenza, Human/*prevention & control
Logistic Models
Male
Middle Aged
Nutrition Surveys
Odds Ratio
Pulmonary Disease, Chronic Obstructive/diagnosis
Republic of Korea
Respiratory Function Tests
Vaccination/*statistics & numerical data
Influenza Vaccines

Reference

1. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007; 357:1373–1381.

2. Rothberg MB, Rose DN. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Am J Med. 2005; 118:68–77.

3. Ting SC, Crooks SW, South G. The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period. J Epidemiol Community Health. 2011; 65:157–159.

4. Simonsen L, Viboud C, Taylor R. Influenza vaccination in elderly people. Lancet. 2005; 366:2086.

5. Park SC, Cheong HJ, Sohn JW, Choi SJ, Eom JS, Woo HJ, Chun BC, Kim WJ. Efficacy of influenza vaccination among chronic ill patients: retrospective case control study. Infect Chemother. 2004; 36:207–212.

6. Lim J, Eom CS, Kim KH, Kim S, Cho B. Coverage of influenza vaccination among elderly in South Korea: a population based cross sectional analysis of the season 2004–2005. J Korean Geriatr Soc. 2009; 13:215–221.

7. Kee SY, Lee JS, Cheong HJ, Chun BC, Song JY, Choi WS, Jo YM, Seo YB, Kim WJ. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect. 2007; 55:273–281.

8. Park MB, Kim CB, Joo HS. Factors influencing on influenza vaccination coverage. J Korea Contents Assoc. 2013; 13:300–311.

9. Ministry of Health and Welfare (KR). Korea National Health and Nutrition Examination Survey. Available at http://knhanes.cdc.go.kr.

10. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: update 2013. Available at http://www.goldcopd.org.

11. Kroneman M, van Essen GA, John Paget W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine. 2006; 24:622–628.

12. Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health. 2008; 8:272–282.

13. Blank PR, Schwenkglenks M, Szucs TD. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons. Infection. 2009; 37:390–400.

14. Linn ST, Guralnik JM, Patel KV. Disparities in influenza vaccine coverage in the United States, 2008. J Am Geriatr Soc. 2010; 58:1333–1340.

15. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, Yoon HI, Lim SC, Park JY, Park SJ, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology. 2011; 16:659–665.

16. Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, Heels-Ansdell DM, Erak M, Bragaglia PJ, Tamari IE, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010; 182:673–678.

17. Mapel DW, Dalal AA, Johnson P, Becker L, Hunter AG. A clinical study of COPD severity assessment by primary care physicians and their patients compared with spirometry. Am J Med. 2015; 128:629–637.

18. Mowls DS, Cheruvu VK, Zullo MD. Influenza vaccination in adults with chronic obstructive pulmonary disease: the impact of a diagnostic breathing test on vaccination rates. PLoS One. 2013; 8:e67600.

19. Dower J, Donald M, Begum N, Vlack S, Ozolins I. Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia. Vaccine. 2011; 29:3031–3037.

20. Yeung MP, Ng SK, Tong ET, Chan SS, Coker R. Factors associated with uptake of influenza vaccine in people aged 50 to 64 years in Hong Kong: a case-control study. BMC Public Health. 2015; 15:617.

21. Choi KH, Park SM, Lee K, Lee JH, Park JS. Influenza vaccination and associated factors among Korean cancer survivors: a cross-sectional analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys. J Korean Med Sci. 2014; 29:1061–1068.

22. Zheng Y, Yang P, Wu S, Ma C, Seale H, Macintyre CR, Wang Q. A cross-sectional study of factors associated with uptake of vaccination against influenza among older residents in the postpandemic season in Beijing, China. BMJ Open. 2013; 3:e003662.

23. Kee SY, Cheong HJ, Chun BC, Kim WJ. Influenza vaccination coverage rate and factors associated with vaccination in people with chronic disease. Infect Chemother. 2011; 43:406–411.

24. Damiani G, Federico B, Visca M, Agostini F, Ricciardi W. The impact of socioeconomic level on influenza vaccination among Italian adults and elderly: a cross-sectional study. Prev Med. 2007; 45:373–379.

25. Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine. 2009; 27:4018–4024.

26. Sevencan F, Ertem M, Özçullu N, Dorman V, Kubat NK. The evaluation of the opinions and attitudes of healthcare personnel of the province Diyarbakir against influenza A (H1N1) and the vaccination. Hum Vaccin. 2011; 7:945–951.